Back

We need to add a risk score to hs-troponin - Discussion.

3 March 2019 (09:54 - 10:00)
Organised by:
Congress Presentation Part of: Controversies in diagnostic strategies for chest pain patients Acute Coronary Syndromes ACVC Premium Access Acute Cardiovascular Care 2019

5 More presentations in this session

Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. PRO.
Professor B. Lindahl (Uppsala, SE)
Slides
Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. CONTRA.
Professor M. Moeckel (Berlin, DE)
Slides Video
Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. Discussion.
Presentation thumbnail
We need to add a risk score to hs-troponin - PRO.
Doctor M. Tubaro (Rome, IT)
Slides Video
Presentation thumbnail
We need to add a risk score to hs-troponin - CONTRA.
Professor J. Boeddinghaus (Basel, CH)
Slides Video

Access the full session

Session thumbnail
Controversies in diagnostic strategies for chest pain patients

The Event

Event poster

Acute Cardiovascular Care 2019

3 March 2019 09:54 CET
You may be interested in
thumbnail
Congress Presentation
Rethinking risk stratification in acute chest pain: limited value of HEAR and GRACE scores in the high-sensitivity troponin era from a brazilian cohort
20 March 2026
thumbnail
Congress Session
Great Debate: the calcium score is essential in cardiovascular disease risk assessment
29 August 2022
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Influence of novel risk markers on defibrillator implantation in hypertrophic cardiomyopathy
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources